Associations of outdoor fine particulate air pollution and cardiovascular disease in 157 436 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.


Journal

The Lancet. Planetary health
ISSN: 2542-5196
Titre abrégé: Lancet Planet Health
Pays: Netherlands
ID NLM: 101704339

Informations de publication

Date de publication:
06 2020
Historique:
received: 14 11 2019
revised: 19 03 2020
accepted: 21 04 2020
pubmed: 20 6 2020
medline: 29 12 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

Most studies of long-term exposure to outdoor fine particulate matter (PM In this multinational, prospective cohort study, we studied 157 436 adults aged 35-70 years who were enrolled in the PURE study in countries with ambient PM Between Jan 1, 2003, and July 14, 2018, 157 436 adults from 747 communities in 21 high-income, middle-income, and low-income countries were enrolled and followed up, of whom 140 020 participants resided in LMICs. During a median follow-up period of 9·3 years (IQR 7·8-10·8; corresponding to 1·4 million person-years), we documented 9996 non-accidental deaths, of which 3219 were attributed to cardiovascular disease. 9152 (5·8%) of 157 436 participants had cardiovascular disease events (fatal and non-fatal incident cardiovascular disease), including 4083 myocardial infarctions and 4139 strokes. Mean 3-year PM Long-term outdoor PM Full funding sources are listed at the end of the paper (see Acknowledgments).

Sections du résumé

BACKGROUND
Most studies of long-term exposure to outdoor fine particulate matter (PM
METHODS
In this multinational, prospective cohort study, we studied 157 436 adults aged 35-70 years who were enrolled in the PURE study in countries with ambient PM
FINDINGS
Between Jan 1, 2003, and July 14, 2018, 157 436 adults from 747 communities in 21 high-income, middle-income, and low-income countries were enrolled and followed up, of whom 140 020 participants resided in LMICs. During a median follow-up period of 9·3 years (IQR 7·8-10·8; corresponding to 1·4 million person-years), we documented 9996 non-accidental deaths, of which 3219 were attributed to cardiovascular disease. 9152 (5·8%) of 157 436 participants had cardiovascular disease events (fatal and non-fatal incident cardiovascular disease), including 4083 myocardial infarctions and 4139 strokes. Mean 3-year PM
INTERPRETATION
Long-term outdoor PM
FUNDING
Full funding sources are listed at the end of the paper (see Acknowledgments).

Identifiants

pubmed: 32559440
pii: S2542-5196(20)30103-0
doi: 10.1016/S2542-5196(20)30103-0
pmc: PMC7457447
mid: NIHMS1615420
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e235-e245

Subventions

Organisme : NIH HHS
ID : DP5 OD019850
Pays : United States
Organisme : CIHR
ID : 136893
Pays : Canada

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

Am Heart J. 2009 Jul;158(1):1-7.e1
pubmed: 19540385
Environ Int. 2018 May;114:307-317
pubmed: 29567495
Environ Health Perspect. 2019 May;127(5):57003
pubmed: 31067132
Environ Int. 2018 Aug;117:99-106
pubmed: 29730535
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
N Engl J Med. 2017 Jun 29;376(26):2513-2522
pubmed: 28657878
N Engl J Med. 2019 Aug 22;381(8):705-715
pubmed: 31433918
Environ Sci Technol. 2018 Aug 21;52(16):9069-9078
pubmed: 29957991
Environ Sci Technol. 2016 Jan 5;50(1):79-88
pubmed: 26595236
Environ Health Perspect. 2017 Nov 07;125(11):117002
pubmed: 29116930
J Am Coll Cardiol. 2018 Oct 23;72(17):2054-2070
pubmed: 30336830
Lancet. 2020 Mar 7;395(10226):785-794
pubmed: 31492501
Lancet Public Health. 2018 Oct;3(10):e470-e477
pubmed: 30314593
Air Qual Atmos Health. 2016;9(8):961-972
pubmed: 27867428
Am J Hypertens. 2017 Apr 1;30(4):373-381
pubmed: 28096145
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9592-9597
pubmed: 30181279
Lancet. 2020 Mar 7;395(10226):795-808
pubmed: 31492503
Environ Health Perspect. 2014 Sep;122(9):919-25
pubmed: 24835336
Am Heart J. 2013 Oct;166(4):636-646.e4
pubmed: 24093842
Lancet. 2018 Jun 2;391(10136):2236-2271
pubmed: 29893224
Neurology. 2017 May 2;88(18):1709-1717
pubmed: 28363975
Environ Sci Technol. 2016 Apr 5;50(7):3762-72
pubmed: 26953851
BMJ. 2019 Dec 30;367:l6720
pubmed: 31888885
JAMA Cardiol. 2017 Apr 1;2(4):353-354
pubmed: 28241232
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Int J Epidemiol. 2020 Feb 1;49(1):25-35
pubmed: 31289812
Lancet. 2004 Sep 11-17;364(9438):937-52
pubmed: 15364185
N Engl J Med. 2014 Aug 28;371(9):818-27
pubmed: 25162888
Environ Health Perspect. 2012 May;120(5):708-14
pubmed: 22313724
Environ Res. 2018 Oct;166:677-689
pubmed: 30077140
N Engl J Med. 2007 Feb 1;356(5):447-58
pubmed: 17267905

Auteurs

Perry Hystad (P)

College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. Electronic address: perry.hystad@oregonstate.edu.

Andrew Larkin (A)

College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.

Sumathy Rangarajan (S)

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.

Khalid F AlHabib (KF)

Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Álvaro Avezum (Á)

Department of Medicine, Universidade de Santo Amaro, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.

Kevser Burcu Tumerdem Calik (KBT)

Department of Health Management, Faculty of Health Sciences, Marmara University, Istanbul, Turkey.

Jephat Chifamba (J)

Department of Physiology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Antonio Dans (A)

Department of Cardiac Sciences, University of Philippines, Manila, Philippines.

Rafael Diaz (R)

Estudios Clínicos Latinoamérica (ECLA), Rosario, Santa Fe, Argentina.

Johan L du Plessis (JL)

Occupational Hygiene and Health Research Initiative, North-West University, Potchefstroom, South Africa.

Rajeev Gupta (R)

Eternal Heart Care Centre and Research Institute, Jaipur, India.

Romaina Iqbal (R)

Department of Community Health Sciences and Medicine, Aga Khan University, Karachi, Pakistan.

Rasha Khatib (R)

Institute for Community and Public Health, Birzeit University, Birzeit, Palestine; Advocate Health Care, Chicago, IL, USA.

Roya Kelishadi (R)

Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Fernando Lanas (F)

Department of Medicine, Universidad de La Frontera, Temuco, Chile.

Zhiguang Liu (Z)

Jockey Club School of Public Health and Primary Care, the Chinese University of Hong Kong, Prince of Wales Hospital, Sha Tin, Hong Kong.

Patricio Lopez-Jaramillo (P)

Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle (FOSCAL), Bucaramanga, Colombia; Escuela de Medicina, Universidad de Santander, Bucaramanga, Colombia.

Sanjeev Nair (S)

Health Action by People, Thiruvananthapuram, India.

Paul Poirier (P)

Faculty of Pharmacy, University Institute of Cardiology and Respirology of Quebec, Laval University, Québec, QC, Canada.

Omar Rahman (O)

Independent University, Dhaka, Bangladesh.

Annika Rosengren (A)

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

Hany Swidan (H)

Dubai Health Authority, Dubai, United Arab Emirates.

Lap Ah Tse (LA)

Jockey Club School of Public Health and Primary Care, the Chinese University of Hong Kong, Prince of Wales Hospital, Sha Tin, Hong Kong.

Li Wei (L)

National Centre for Cardiovascular Diseases, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Andreas Wielgosz (A)

Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Karen Yeates (K)

Department of Medicine, Queen's University, Kingston, ON, Canada.

Khalid Yusoff (K)

Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia; UCSI University, Cheras, Kuala Lumpur, Malaysia.

Tomasz Zatoński (T)

Department of Otolaryngology Head and Neck Surgery, Wrocław Medical University, Wrocław, Poland.

Rick Burnett (R)

Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.

Salim Yusuf (S)

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.

Michael Brauer (M)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH